申请人:TAIVEX THERAPEUTICS CORPORATION
                            
                            
                                公开号:US10588909B2
                            
                            
                                公开(公告)日:2020-03-17
                            
                            
Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
                            本文提供了调节 Hec1/Nek2 相互作用的化合物、组合物和方法。这些化合物能破坏 Nek2/Hec1 的结合,可用作肿瘤疾病的化疗药物。